Benefits of cladribine tablets on the proportion of patients with multiple sclerosis free from clinical and radiological indicators of disease activity in the CLARITY EXTENSION study

被引：0
|
作者：
Giovannoni, G. [1 ]
Comi, G. [2 ,3 ]
Cook, S. [4 ]
Rieckmann, P. [5 ]
Rammohan, K. [6 ]
Soelberg-Sorensen, P. [7 ]
Vermersch, P. [8 ]
Adeniji, A. [9 ]
Dangond, F. [9 ]
机构：
[1] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[2] Univ Vita Salute San Raffaele, Osped San Raffaele, Dept Neurol, Milan, Italy
[3] Univ Vita Salute San Raffaele, Osped San Raffaele, Inst Expt Neurol, Milan, Italy
[4] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA
[5] Akad Krankenhaus Sozialstiftung, Neurol Klin, Bamberg, Germany
[6] Ohio State Univ Hosp, Columbus, OH 43210 USA
[7] Copenhagen Univ Hosp, Dept Neurol, Danish MS Ctr, Copenhagen, Denmark
[8] Univ Lille, CHU Lille, LIRIC, INSERM,U 995, Lille, France
[9] EMD Serono Inc, Billerica, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P636
引用
收藏
页码：300 / 301
页数：2
相关论文
共 50 条
  • [21] The Effect Of Cladribine Tablets In Patients With Relapsing-remitting Multiple Sclerosis Who Had Evidence Of Disease Activity In CLARITY
    Greenberg, B. M.
    Rammohan, K.
    Aldridge, J.
    Lebson, L. A.
    Dangond, F.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 50 - 50
  • [22] Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY Extension
    Giovannoni, Gavin
    Keller, Birgit
    Jack, Dominic
    NEUROLOGY, 2019, 92 (15)
  • [23] Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY extension
    Giovannoni, G.
    Keller, B.
    Jack, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 479 - 480
  • [24] Durability of NEDA-3 Status in Patients with Relapsing Multiple Sclerosis Receiving Cladribine Tablets: CLARITY Extension
    Giovannoni, Gavin
    Keller, Birgit
    Jack, Dominic
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 47 - 48
  • [25] Efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS) in the 120-week extension to the CLARITY study
    Giovannoni, Gavin
    Comi, Giancarlo
    Cook, Stuart
    Rieckmann, Peter
    Rammohan, Kottil
    Soelberg-Soerensen, Per
    Vermersch, Patrick
    Martin, Emily
    Dangond, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP6 - NP7
  • [26] Durability of NEDA-3 Status in Patients with Relapsing Multiple Sclerosis Receiving Cladribine Tablets: CLARITY Extension
    Giovannoni, G.
    Keller, B.
    Jack, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 467 - 467
  • [27] Consistent reductions in MRI activity with cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis in the CLARITY study
    Comi, G.
    Cook, S.
    Giovannoni, G.
    Rammohan, K.
    Rieckmann, P.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Hamlett, A.
    Musch, B.
    Fevr, T.
    Viglietta, V.
    Greenberg, S. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 485 - 485
  • [28] Efficacy of Cladribine Tablets 3.5 mg/kg in High Disease Activity (HDA) Subgroups of Patients with Relapsing Multiple Sclerosis (RMS) in the CLARITY Study
    Giovannoni, Gavin
    Rammohan, Kottil
    Cook, Stuart
    Comi, Giancarlo
    Rieckmann, Peter
    Soelberg-Sorensen, Per
    Vermersch, Patrick
    Dangond, Fernando
    Hicking, Christine
    NEUROLOGY, 2017, 88
  • [29] Efficacy of Cladribine Tablets 3.5 mg/ kg in High Disease Activity (HDA) Subgroups of Patients with Relapsing Multiple Sclerosis (RMS) in the CLARITY Study
    Giovannoni, Gavin
    Rammohan, Kottil
    Cook, Stuart
    Comi, Giancarlo
    Rieckmann, Peter
    Soelberg-Sorensen, Per
    Vermersch, Patrick
    Dangond, Fernando
    Hicking, Christine
    King, John
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 396 - 397
  • [30] Efficacy of cladribine tablets 3.5 mg/kg in high disease activity (HDA) subgroups of patients with relapsing multiple sclerosis (RMS) in the CLARITY study
    Giovannoni, Gavin
    Rammohan, Kottil
    Cook, Stuart
    Comi, Giancarlo
    Rieckmann, Peter
    Soelberg-Sorensen, Per
    Vermersch, Patrick
    Dangond, Fernando
    Hicking, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP6 - NP6
12345